The health-related quality of life in Iranian patients with COVID-19

Alinia, Cyrus; Yaghmaei, Safura; Abdullah, Farman Zahir; Ahmadi, Amin; Samadi, Nasrin; Pourteimour, Sima; Safari, Hossein; Mahmoodi, Hassan; Moradi, Ghobad; Piroozi, Bakhtiar

doi:10.1186/s12879-021-06170-z

Cited by 15 publications

(18 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It was seen that the disease had not only physical signs and symptoms in the short term but also in the long term, and so a condition known as the “long-COVID” syndrome was described ( Cirulli et al, 2020 ; Sudre et al, 2020 ). Since the spread of the disease and it becoming a global crisis, a growing body of evidence has begun to indicate that the clinical picture would not be limited to vital and physical dimensions, and that psychological and social consequences of the disease have also become critical effects across multiple populations ( Ali & Alharbi, 2020 ; Alimoradi et al., 2021 ; Alinia et al., 2021 ; Armbruster & Klotzbücher, 2020 ; X. Li et al, 2021 ).…”

Section: Discussionmentioning

confidence: 99%

“…While some patients reported being asymptomatic, some non-hospitalized patients reported COVID-19 symptoms that extended well beyond the expected time period for recovery ( Huang et al., 2020 ; Lai et al., 2020 ; Xu et al., 2020 ). Severity of initial symptom presentation, the types of symptoms, as well as functional impairment and physical and psychological health are affected to different degrees ( Alinia et al, 2021 ; Carenzo et al, 2021 ; Temperoni et al, 2021 ). While there is substantial evidence in the literature, especially for hospitalized patients, the functional or daily impacts of non-hospitalized patients are relatively less emphasized.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The Symptom Experience and Functioning of Non-Hospitalized COVID-19 Patients Within the First 20 days

et al. 2023

View full text Add to dashboard Cite

The adverse physical, psychological, and mental health consequences associated with COVID-19 illness are well-documented. However, how specific symptoms change over time and how COVID-19 affects one’s day-to-day activities of daily living (ADL), Quality of Life (QoL), sleep quality, and fatigue severity are not well described. This longitudinal and descriptive study examined the changes in COVID-19 symptoms, ADL, QoL, sleep quality, and fatigue severity within the first 20 days. A convenience sample ( n = 41) of non-hospitalized SARS-CoV-2 positive patients were recruited and followed for 20 days. Participants completed self-report measures: COVID-19 symptoms, ADL, QoL, sleep quality, and fatigue severity at days: 1, 10, and 20 following a diagnosis. Findings revealed that symptoms decreased over 20 days ( p < .001). In parallel with the decrease in symptoms, QoL and ADL improved over 20 days ( p < .05). However, sleep quality and fatigue severity did not improve within 20 days ( p > .05). Our findings contribute to the growing evidence that COVID-19 symptoms can linger, especially fatigue and sleep quality, that affect overall day-to-day functioning for at least 20 days after diagnosis. To mitigate the effect of COVID-19 on QOL and ADL, findings underscore the need for clinicians to work collaboratively with patients to develop a symptom management plan for a variety of symptoms including fatigue and sleep quality. Beginning to repurpose existing self-management strategies for the longer term COVID-19 symptoms could be beneficial and help to optimize patient outcomes. Future work should examine these variables over a longer timeframe and among different samples of non-hospitalized patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

The Symptom Experience and Functioning of Non-Hospitalized COVID-19 Patients Within the First 20 days

et al. 2023

View full text Add to dashboard Cite

show abstract

“…There was a lack of utility scores for different COVID-19 health statuses in the Chinese population. Thus, we used an Iran study focusing on the health utility value of patients with COVID-19, and the utility scores from the Iran population were more representative of the Asian population and covered all health statuses in our model [ 45 ]. The utility of people of susceptible statuses was referred to in the paper, focusing on the norms for EQ-5D-5L among the Chinese general population, given that the general population does not have full health [ 46 ].…”

Section: Methodsmentioning

confidence: 99%

Cost-Effectiveness of COVID-19 Sequential Vaccination Strategies in Inactivated Vaccinated Individuals in China

Zhao

Wei

et al. 2022

Vaccines

View full text Add to dashboard Cite

To effectively prevent and control the COVID-19 pandemic, countries have adopted a booster vaccination strategy. This study aimed to estimate the cost-effectiveness of sequential booster COVID-19 vaccination compared to two-dose inactivated vaccination in China from a societal perspective. A Markov model was developed to estimate the cost-effectiveness of sequential vaccination, including two doses of an inactivated vaccine followed by a booster shot of an inactivated vaccine, adenovirus vectored vaccine, protein subunit vaccine, or mRNA vaccine. The incremental effects of a booster shot with an inactivated vaccine, protein subunit vaccine, adenovirus vectored vaccine, and mRNA vaccine were 0.0075, 0.0110, 0.0208, and 0.0249 QALYs and saved costs of US$163.96, US$261.73, US$583.21, and US$724.49, respectively. Under the Omicron virus pandemic, the sequential vaccination among adults and the elderly (aged 60–69, 70–79, over 80) was consistently cost-saving, and a booster shot of the mRNA vaccine was more cost-saving. The results indicate that the sequential vaccination strategy is cost-effective in addressing the COVID-19 pandemic, and improving vaccination coverage among the elderly is of great importance in avoiding severe cases and deaths.

show abstract

“…However, only few studies have reported HRQoL of patients after discharge. One study has revealed that COVID-19 is associated with a substantial and measurable decrease in HRQoL, and the age and hospitalization status of participants were the key determinants of their COVID-19 health utility value ( 10 ). Further evidence suggests that, even though physical function was recovered, patients might still have mental disorders ( 11 ), which could affect them even after 1 year ( 12 ).…”

Section: Introductionmentioning

confidence: 99%

Early Mental Health and Quality of Life in Discharged Patients With COVID-19

Zhang

Xue

et al. 2021

Front. Public Health

View full text Add to dashboard Cite

Aim: This study aimed to analyze the early mental health (MH) and quality of life (QoL) of discharged patients with coronavirus disease 2019 (COVID-19), which can provide a scientific basis for the further development of intervention programs.Methods: In total, 108 subjects participated in this study, including an experimental group (90 patients diagnosed with COVID-19 from March to April 2020 and hospitalized in Wuhan China Resources & WISCO General Hospital, Wuhan, China, 83.3%) and a control group (18 healthy participants, 16.7%). Their MH and QoL were measured through the 12-item Short Form Health Survey version 2 (SF-12v2), the Self-rating anxiety scale (SAS), the Self-rating depression scale (SDS), and the International Physical Activity Questionnaire (IPAQ). The results of questionnaires were compared between these two groups.Results: (1) Comparison of anxiety status: among 90 discharged patients with COVID-19, 30 patients (33.3%) had a state of anxiety. Compared with healthy participants and the general population, patients with COVID-19 in the early stages of discharge had a higher incidence of anxiety and more severe anxiety symptoms (P < 0.05). (2) Comparison of depression status: among 90 discharged patients with COVID-19, 29 patients (32.2%) had a state of depression. Compared with healthy participants and the general population, patients with COVID-19 in the early stages of discharge had a higher incidence of depression and more severe depression symptoms (P < 0.05). (3) Comparison of QoL: 78 patients (86.7%) presented a decrease in physical health-related quality of life (HRQoL) and 73 patients (81.1%) presented a decrease in psychology-related QoL. The SF-12v2 physical component summary (PCS) and the SF-12v2 mental component summary (MCS) of patients were significantly lower than those of healthy people, especially in physical function (PF), vitality (VT), social function (SF), and mental health (MH) (all P < 0.05). (4) Gender differences in mental health and the QoL among patients with COVID-19: women had more severe anxiety/depression symptoms than men (P < 0.05). The scores of women in all dimensions of SF-12V2 were lower than those of men, and there were statistically significant differences between the two groups in PCS, PF, general health (GH), VT, and role-emotional (RE) (P < 0.05).Conclusion: During the early phase after being discharged, patients with COVID-19 might experience negative emotions, such as anxiety or depression, and also problems with reduced QoL, especially among female patients. Therefore, an intervention plan should focus on strengthening psychological condition and improving physical function, and gender-specific rehabilitation programmes should be adapted to improve psychological status and QoL.

show abstract

The health-related quality of life in Iranian patients with COVID-19

Cited by 15 publications

References 28 publications

The Symptom Experience and Functioning of Non-Hospitalized COVID-19 Patients Within the First 20 days

The Symptom Experience and Functioning of Non-Hospitalized COVID-19 Patients Within the First 20 days

Cost-Effectiveness of COVID-19 Sequential Vaccination Strategies in Inactivated Vaccinated Individuals in China

Early Mental Health and Quality of Life in Discharged Patients With COVID-19

Contact Info

Product

Resources

About